Medicine News and Research

RSS

Study compares latest drug-coated stents with traditional bypass surgery

Newer drug-coated stents that keep arteries open have similar long-term rates of death compared with traditional bypass surgery for patients with more than one diseased coronary artery.

17 Mar 2015

Routine cardiac CT scan may help reduce heart attack risk

Routine heart scans for patients referred to cardiac clinics with chest pain could reduce heart attack rates, research suggests.

17 Mar 2015

Broad array of clinical, health care policy topics to be featured at ACP's Internal Medicine Meeting

More than 6,000 internal medicine physicians, subspecialists, medical students, and allied health professionals from around the world will gather for the American College of Physicians' Internal Medicine Meeting 2015 from April 30 through May 2 (Thursday - Saturday) at the Boston Convention and Exhibition Center.

17 Mar 2015

Raja Atreya wins award for novel diagnostic method to predict treatment outcomes in Crohn's disease

Professor Raja Atreya from Medical Clinic 1 of the Erlangen University Hospital has won the 60,000€ Paul Ehrlich and Ludwig Darmstaedter Prize for Young Researchers for 2015. With his innovative diagnostic method, physicians can predict the clinical response of an expensive treatment of Crohn's disease which is associated with potential side effects.

17 Mar 2015

Majority of doctors welcome additional training in diet, nutrition to prevent CVD

Most physicians are aware of the importance of lifestyle factors in preventing cardiovascular disease (CVD) -- and believe diet is as important as statin therapy and exercise, according to a new survey from NYU Langone Medical Center.

17 Mar 2015

NYU Langone Medical Center researchers find that air pollution may pose significant stroke risk

Air pollution has been linked to a dangerous narrowing of neck arteries that occurs prior to strokes, according to researchers at NYU Langone Medical Center.

17 Mar 2015

Study may help men make better decisions about aggressive prostate cancer treatments

A Northwestern University-led study in the emerging field of nanocytology could one day help men make better decisions about whether or not to undergo aggressive prostate cancer treatments.

17 Mar 2015

Cook Medical receives CE Mark for new thumbwheel deployment system for Zilver PTX drug-eluting peripheral stent

CE Mark has been awarded to the new rotating thumbwheel deployment system for Cook Medical’s Zilver PTX drug-eluting peripheral stent. The new system, which is now available for purchase in the UK, Ireland, Germany, Spain and Italy, provides simple deployment for the world’s first and only approved drug-eluting stent for the superficial femoral artery (SFA).

17 Mar 2015

Comprehensive review of sex hormones' role in female reproductive tract

Charles R. Wira, PhD, and colleagues at Dartmouth's Geisel School of Medicine have presented a comprehensive review of the role of sex hormones in the geography of the female reproductive tract and evidence supporting a "window of vulnerability" to HIV and other sexually transmitted infections (STIs).

17 Mar 2015

New hepatitis C drugs to place economic burden on health care system, predicts MD Anderson study

The cost of treating people infected with the hepatitis C virus (HCV) with newly approved therapies will likely place a tremendous economic burden on the country's health care system. The prediction comes from a cost-effectiveness analysis led by researchers at The University of Texas MD Anderson Cancer Center.

17 Mar 2015

Study defines new subtype of 'lethal' prostate cancer

A University of Colorado Cancer Center study published in the journal Cancer Research defines a new, distinct subtype of "lethal" prostate cancer marked by the loss of two genes, MAP3K7 and CHD1. Overall about 10 percent of men with prostate cancer will die from the disease.

16 Mar 2015

NantWorks, Sorrento collaborate to discover and develop novel anti-cancer immunotherapies

NantWorks, Inc. and Sorrento Therapeutics, Inc., announced today that they have entered into a binding agreement to initiate a global collaboration to discover and develop novel anti-cancer immunotherapies derived from Sorrento's proprietary G-MAB library against neoepitopes of tumor-specific antigens discovered using NantWorks' proprietary pan-omics based, precision medicine approach.

16 Mar 2015

New vaccine for post exposure treatment of rabies infection enters human clinical trial

Yisheng Biopharma Co., Ltd., a biopharmaceutical company focusing on the research, development, manufacturing, sales and marketing of vaccine products, announced that a new vaccine for the post exposure treatment of the rabies infection was entering human clinical trial after a six-year long collaboration with a number of research institutes worldwide.

16 Mar 2015

New risk-evaluation protocol can help emergency departments evaluate chest-pain patients

A recently developed risk-evaluation protocol can help hospital emergency department personnel more efficiently determine which patients with acute chest pain can be sent home safely, according to a randomized trial conducted at Wake Forest Baptist Medical Center.

16 Mar 2015

Scientists use x-ray vision to probe early stages of DNA 'photocopying'

Scientists at Johns Hopkins have created a 3-D model of a complex protein machine, ORC, which helps prepare DNA to be duplicated.

16 Mar 2015

Common herpes drug Valacyclovir decreases HIV-1 levels

Case Western Reserve researchers are part of an international team that has discovered that a common herpes drug reduces HIV-1 levels — even when patients do not have herpes.

16 Mar 2015

Loyola's Bridget Boyd suggests ways to handle diaper rash

Diaper rash may not be a serious condition, but it can be extremely painful. It is common and causes concern for many parents trying to comfort their child.

16 Mar 2015

Results of pacritinib Phase 2 study in myelofibrosis patients published in journal 'Blood'

CTI BioPharma Corp. today announced that results of a Phase 2 study of pacritinib, in patients with myelofibrosis were published in the journal Blood. Pacritinib is a next-generation oral JAK2/FLT3 multikinase inhibitor currently in Phase 3 development in the PERSIST program.

16 Mar 2015

Yale researchers test new device that protects patients' brain during heart-valve replacement procedure

In the first multicenter trial of its kind, Yale researchers tested a new device that lowers the risk of stroke and cognitive decline in patients undergoing heart-valve replacement.

16 Mar 2015

Combined use of enalapril and folic acid can significantly reduce risk of first stroke

In a study that included more than 20,000 adults in China with high blood pressure but without a history of stroke or heart attack, the combined use of the hypertension medication enalapril and folic acid, compared with enalapril alone, significantly reduced the risk of first stroke, according to a study appearing in JAMA. The study is being released to coincide with its presentation at the American College of Cardiology Annual Scientific Session.

16 Mar 2015

Medicine News and Research

Study compares latest drug-coated stents with traditional bypass surgery

Routine cardiac CT scan may help reduce heart attack risk

Broad array of clinical, health care policy topics to be featured at ACP's Internal Medicine Meeting

Raja Atreya wins award for novel diagnostic method to predict treatment outcomes in Crohn's disease

Majority of doctors welcome additional training in diet, nutrition to prevent CVD

NYU Langone Medical Center researchers find that air pollution may pose significant stroke risk

Study may help men make better decisions about aggressive prostate cancer treatments

Cook Medical receives CE Mark for new thumbwheel deployment system for Zilver PTX drug-eluting peripheral stent

Comprehensive review of sex hormones' role in female reproductive tract

New hepatitis C drugs to place economic burden on health care system, predicts MD Anderson study

Study defines new subtype of 'lethal' prostate cancer

NantWorks, Sorrento collaborate to discover and develop novel anti-cancer immunotherapies

New vaccine for post exposure treatment of rabies infection enters human clinical trial

New risk-evaluation protocol can help emergency departments evaluate chest-pain patients

Scientists use x-ray vision to probe early stages of DNA 'photocopying'

Common herpes drug Valacyclovir decreases HIV-1 levels

Loyola's Bridget Boyd suggests ways to handle diaper rash

Results of pacritinib Phase 2 study in myelofibrosis patients published in journal 'Blood'

Yale researchers test new device that protects patients' brain during heart-valve replacement procedure

Combined use of enalapril and folic acid can significantly reduce risk of first stroke

Everything there is to know about biosimilars eBook

Improving healthcare sustainability through carbon data

Managing vibration in IVF laboratories

A New Approach to Preventing Bladder Cancer Recurrence

Latest News